Cargando…

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib

Detalles Bibliográficos
Autores principales: Yamamura, Yuriko, Matsumoto, Yoshinori, Asano, Yosuke, Katayama, Yu, Hayashi, Keigo, Ohashi, Keiji, Morishita, Michiko, Watanabe, Haruki, Takano-Narazaki, Mariko, Sada, Ken-Ei, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991178/
https://www.ncbi.nlm.nih.gov/pubmed/32016168
http://dx.doi.org/10.1093/rap/rkz050
_version_ 1783492604233515008
author Yamamura, Yuriko
Matsumoto, Yoshinori
Asano, Yosuke
Katayama, Yu
Hayashi, Keigo
Ohashi, Keiji
Morishita, Michiko
Watanabe, Haruki
Takano-Narazaki, Mariko
Sada, Ken-Ei
Wada, Jun
author_facet Yamamura, Yuriko
Matsumoto, Yoshinori
Asano, Yosuke
Katayama, Yu
Hayashi, Keigo
Ohashi, Keiji
Morishita, Michiko
Watanabe, Haruki
Takano-Narazaki, Mariko
Sada, Ken-Ei
Wada, Jun
author_sort Yamamura, Yuriko
collection PubMed
description
format Online
Article
Text
id pubmed-6991178
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-69911782020-02-03 Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib Yamamura, Yuriko Matsumoto, Yoshinori Asano, Yosuke Katayama, Yu Hayashi, Keigo Ohashi, Keiji Morishita, Michiko Watanabe, Haruki Takano-Narazaki, Mariko Sada, Ken-Ei Wada, Jun Rheumatol Adv Pract Case Report Oxford University Press 2019-12-23 /pmc/articles/PMC6991178/ /pubmed/32016168 http://dx.doi.org/10.1093/rap/rkz050 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yamamura, Yuriko
Matsumoto, Yoshinori
Asano, Yosuke
Katayama, Yu
Hayashi, Keigo
Ohashi, Keiji
Morishita, Michiko
Watanabe, Haruki
Takano-Narazaki, Mariko
Sada, Ken-Ei
Wada, Jun
Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
title Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
title_full Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
title_fullStr Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
title_full_unstemmed Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
title_short Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
title_sort refractory takayasu arteritis responding to the oral janus kinase inhibitor, tofacitinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991178/
https://www.ncbi.nlm.nih.gov/pubmed/32016168
http://dx.doi.org/10.1093/rap/rkz050
work_keys_str_mv AT yamamurayuriko refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT matsumotoyoshinori refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT asanoyosuke refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT katayamayu refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT hayashikeigo refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT ohashikeiji refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT morishitamichiko refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT watanabeharuki refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT takanonarazakimariko refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT sadakenei refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib
AT wadajun refractorytakayasuarteritisrespondingtotheoraljanuskinaseinhibitortofacitinib